- Home
- IMMP vs WALD Comparison
IMMP vs WALD Comparison
Compare IMMP & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- WALD
- Stock Information
- Founded
- IMMP 1987
- WALD 1988
- Country
- IMMP Australia
- WALD United States
- Employees
- IMMP N/A
- WALD N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- WALD Package Goods/Cosmetics
- Sector
- IMMP Health Care
- WALD Consumer Discretionary
- Exchange
- IMMP Nasdaq
- WALD Nasdaq
- Market Cap
- IMMP 251.8M
- WALD 291.5M
- IPO Year
- IMMP N/A
- WALD 2021
- Fundamental
- Price
- IMMP $1.57
- WALD $2.39
- Analyst Decision
- IMMP Buy
- WALD Strong Buy
- Analyst Count
- IMMP 1
- WALD 5
- Target Price
- IMMP $7.00
- WALD $5.16
- AVG Volume (30 Days)
- IMMP 111.5K
- WALD 119.7K
- Earning Date
- IMMP 02-27-2025
- WALD 07-01-2025
- Dividend Yield
- IMMP N/A
- WALD N/A
- EPS Growth
- IMMP N/A
- WALD N/A
- EPS
- IMMP N/A
- WALD N/A
- Revenue
- IMMP $3,019,249.00
- WALD $273,868,000.00
- Revenue This Year
- IMMP $50.37
- WALD $14.78
- Revenue Next Year
- IMMP N/A
- WALD $15.84
- P/E Ratio
- IMMP N/A
- WALD N/A
- Revenue Growth
- IMMP 24.11
- WALD 25.55
- 52 Week Low
- IMMP $1.32
- WALD $1.98
- 52 Week High
- IMMP $2.80
- WALD $4.74
- Technical
- Relative Strength Index (RSI)
- IMMP 36.75
- WALD 50.46
- Support Level
- IMMP $1.51
- WALD $2.09
- Resistance Level
- IMMP $1.63
- WALD $2.50
- Average True Range (ATR)
- IMMP 0.07
- WALD 0.13
- MACD
- IMMP -0.03
- WALD 0.02
- Stochastic Oscillator
- IMMP 14.34
- WALD 68.54
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.